IDEAYA Biosciences Engages in Investor Relations Events
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, is set to participate in an upcoming investor relations event. This event highlights IDEAYA’s commitment to advancing the development of targeted therapeutics aimed at transforming cancer care.
Listen to the Insights at the BTIG Virtual Biotechnology Conference
Details of the Event
On July 29, 2025, IDEAYA will be featured in the prestigious 2025 BTIG Virtual Biotechnology Conference. The event is scheduled to take place at 4:40 PM ET. During this conference, Yujiro S. Hata, the President and Chief Executive Officer of IDEAYA, will engage in a fireside chat hosted by renowned Biotechnology Research Analyst, Justin Zelin.
Accessing Live Webcasts
Interested participants can access a live audio webcast of the conference through the 'Investors/Events' section on the IDEAYA website. The VBTIG conference host will also provide streaming options. Additionally, a recording of the event will be made available for 30 days following the live session, offering flexibility for viewers to catch up on the insights shared.
About IDEAYA Biosciences
IDEAYA is dedicated to the discovery and development of transformative therapies that meet pressing medical needs in oncology. The company employs a sophisticated approach that combines small molecule drug discovery, structural biology, and bioinformatics. By leveraging these capabilities, IDEAYA actively seeks to identify and validate translational biomarkers, driving the creation of potentially first-in-class targeted therapies tailored for specific patient groups.
Innovative Drug Pipeline
The company's robust pipeline includes targeted therapies based on synthetic lethality and antibody-drug conjugates (ADCs), which include bispecifics. IDEAYA's mission centers on improving clinical outcomes for cancer patients through innovative treatment options.
Frequently Asked Questions
What is IDEAYA Biosciences focused on?
IDEAYA specializes in precision medicine for oncology, dedicated to discovering and developing targeted therapies for cancer treatment.
When will IDEAYA participate in the BTIG conference?
IDEAYA will participate in the BTIG Virtual Biotechnology Conference on July 29, 2025, at 4:40 PM ET.
Who is presenting at the conference?
Yujiro S. Hata, the President and CEO of IDEAYA, will present during a fireside chat hosted by Justin Zelin, a Biotechnology Research Analyst.
How can one access the conference webcast?
A live webcast will be available through the IDEAYA website under the 'Investors/Events' section, with a replay accessible for 30 days afterward.
What is the purpose of IDEAYA's investor relations event participation?
Participating in these investor relations events allows IDEAYA to share its advancements, vision, and commitment to developing innovative therapies with investors and the public.